Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting
for
Pressure Ulcers
Location: Durham NC
Sponsor: Precision Fabrics Group, Inc.
Sex: All
Age: 0+
Code: NCT01355666
Recruiting
New
Basal Cell Carcinoma Chemoprevention Trial
for
Basal Cell Carcinoma
Location: Durham NC, Bay Pines FL, Milwaukee WI, Minneapolis MN,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05212246
Phase 3, Recruiting
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Durham NC, Philadelphia PA, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06795529
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
for
Asthma, Obesity
Location: Durham NC
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 65
Code: NCT03885245
Phase 2, Recruiting
Rural Smoking Cessation
for
Smoking Cessation
Location: Durham NC, Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All
Age: 21+
Code: NCT06584929
Recruiting
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
for
Acute Ischemic Stroke
Location: Durham NC, Baltimore MD, Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT06440707
Phase 2, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Durham NC, Cary NC, Raleigh NC, Blacksburg VA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
Optimizing Timing of Cesarean Delivery Consent on Labor and Delivery
for
Pregnancy, Informed Consent
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18+
Code: NCT07117708
Recruiting
Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE): An Intervention to Support Decision Making for Critically Ill Children
for
Decision Making, Neonatal Critical Illness,
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT07390773
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, Birmingham AL, Ann Arbor MI,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906640
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, Houston NC, Birmingham AL, Ann Arbor MI,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906627
Recruiting
Photon-counting CT in Chest Imaging
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT07031336
Recruiting
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
for
Thoracic
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT06075316
Recruiting
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
for
FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers,
Location: Durham NC, New York NY, Rochester MN, Irvine CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18 - 70+
Code: NCT07322094
Phase 1, Phase 2, Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Location: Winston-Salem NC, Chapel Hill NC, Durham NC,
Sponsor: Spyre Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07012395
Phase 2, Recruiting
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)